🩺 Blood Pressure Risk Assessment
| Category | Systolic | Diastolic | Dental Treatment |
|---|
Blood Pressure Management in Dental Practice
Blood pressure measurement before dental treatment is a critical component of medical risk assessment. Hypertension affects approximately 47% of US adults (AHA 2023) — making it one of the most common conditions dental teams encounter. Understanding which BP readings require treatment modification, deferral, or emergency referral protects both patients and practitioners.
For patients requiring local anesthesia, use this checker alongside our Anesthesia Dosage Calculator to select the appropriate agent and vasoconstrictor dose. For medically compromised patients, our Caries Risk Assessment Tool can help prioritise treatment planning.
AHA/ACC 2017 Hypertension Classification
The 2017 AHA/ACC hypertension guidelines lowered the definition of hypertension from 140/90 to 130/80 mmHg — significantly expanding the number of patients classified as hypertensive. For dental practice purposes, the key thresholds remain:
- Normal (<120/80): Routine treatment, no modifications required
- Elevated (120–129/<80): Routine treatment; encourage lifestyle modification and GP follow-up
- Stage 1 HTN (130–139/80–89): Routine treatment with stress-reduction protocol; GP referral if newly detected
- Stage 2 HTN (140–179/90–109): Treatment modification required; stress reduction, limited epi; GP referral for uncontrolled readings
- Hypertensive Urgency (≥180/≥110): Defer elective treatment; emergency care only with monitoring; immediate GP/ED referral
- Hypertensive Crisis (≥180/≥120): No elective treatment; emergency care only; immediate ED referral
Epinephrine in Hypertensive Patients
A common misconception is that epinephrine is contraindicated in hypertensive patients. This is incorrect for controlled hypertension. Good local anesthesia — including epinephrine — prevents pain-mediated endogenous epinephrine release, which produces far greater cardiovascular effects than dental doses of vasoconstrictor.
The AHA/ADA joint advisory limits epinephrine to 0.04 mg per appointment only for patients with significant cardiovascular disease (unstable angina, recent MI within 6 months, recent stroke, uncontrolled arrhythmia, or severe heart failure). This equates to 2.2 cartridges of 1:100,000 or 4.4 cartridges of 1:200,000 solution.